These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5386746)

  • 1. [Clinical experience with a new hepatoprotector].
    Rocca F
    Clin Ter; 1969 Jun; 49(5):473-8. PubMed ID: 5386746
    [No Abstract]   [Full Text] [Related]  

  • 2. [Controlled clinical trial of a new combination of phosphorylcholine, homocysteine-gamma-thiolactone and vitamin B 12 in the parenteral treatment of chronic hepatopathies].
    Bandini S; Monteforte S
    Clin Ter; 1974 Jun; 69(6):549-60. PubMed ID: 4845637
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of liver damage during a course of tuberculosis and chronic pulmonary diseases. Necessity of treatment and new trends].
    Mariani B; Marchioni GF; Capitolo S
    Minerva Med; 1974 Aug; 65(57):2977-89. PubMed ID: 4603931
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trial of a new hepatoprotective preparation].
    Azzena D
    Clin Ter; 1972 Jan; 60(2):143-8. PubMed ID: 5015349
    [No Abstract]   [Full Text] [Related]  

  • 5. [Observations on the treatment of chronic inflammatory liver diseases with the preparation Hepasteril B comp].
    Busse K; Otremba P
    Soins; 1970; 15(7):2608-13. PubMed ID: 4918343
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical treatment of acute and chronic liver diseases].
    Szabb L
    Z Allgemeinmed; 1972 Feb; 48(4):182-4. PubMed ID: 5015143
    [No Abstract]   [Full Text] [Related]  

  • 7. [Our clinical experience with ornithine aspartate].
    Szirmai E
    Minerva Med; 1971 Jun; 62(47):2376-82. PubMed ID: 5087700
    [No Abstract]   [Full Text] [Related]  

  • 8. [The therapeutic value of anabolic steroids in gastroenterology].
    Demole M
    Schweiz Med Wochenschr; 1966 Mar; 96(9):291-6. PubMed ID: 5983996
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of asparagine on hepatic physiopathological syndromes].
    Fodor O; Cotul S; Barbarino F; Grigoras D; Nicoară A; Suciu A
    Stud Cercet Med Interna; 1968; 9(5):405-14. PubMed ID: 5716055
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experimentation with a new hepatotropic agent, EU 2200].
    Linquette M; Decoulx M
    Lille Med; 1966 Nov; 11(9):1051-5. PubMed ID: 5994072
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical research on the hepatoprotective and antianemic action of hepatic opotherapy associated with nucleosides in high doses].
    Bestagno M
    Arch Maragliano Patol Clin; 1966; 22(3):299-309. PubMed ID: 5953073
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experience with the oral liver-therapeutic agent Hepavis].
    Bayazid A; Gerhard W
    Med Welt; 1976 Nov; 27(46):2248-9. PubMed ID: 794616
    [No Abstract]   [Full Text] [Related]  

  • 13. [A hepato-protector in the treatment of long bed-ridden old persons affected with chronic diseases].
    Bonini M
    G Gerontol; 1969 Mar; 17(3):279-86. PubMed ID: 5396389
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunosuppressive treatment of chronic liver diseases in the clinical biochemical, immunological and histological evaluation of the liver].
    Boroń P; Szpakowicz T; Bobrowska E; Boroń-Kaczmarska A; Prokopowicz D; Borzuchowska A
    Z Gesamte Inn Med; 1981 May; 36(10):318-21. PubMed ID: 7303757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical investigation on the possible effects of benzydamine hydrochloride on liver function.
    Vermeulen HJ
    Arzneimittelforschung; 1970 Jun; 20(6):767-70. PubMed ID: 5468890
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation].
    Rapino P; Marulli R; Rapex G; Della Lunga S; Sabatino P
    Minerva Med; 1982 Oct; 73(40):2853-60. PubMed ID: 7133498
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evolution of chronic diffuse liver diseases treated by essential choline phospholipid therapy. Clinical and analytical control through exploration with radioactive isotopes].
    Galán Navarro JL
    Rev Esp Enferm Apar Dig; 1967 Apr; 26(4):460-90. PubMed ID: 5603013
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the therapeutic effectiveness of fructose-1,6-diphosphate in liver diseases. Clinical study].
    Fontana G; Barbara L
    Clin Ter; 1970 Dec; 55(5):407-18. PubMed ID: 5516106
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood oxalate as related to the values of transaminases and blood bilirubin levels in the course of viral hepatitis].
    Battistini G; Riva P; Bianchi A
    G Clin Med; 1969 Jun; 50(6):521-42. PubMed ID: 5386609
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronic liver disease exacerbated during alpha-interferon treatment].
    Rodríguez Moreno F; González Reimers CE; Santolaria Fernández F; García Castro C; Martínez Riera A; Batista López N
    Rev Esp Enferm Dig; 1995 Nov; 87(11):825-7. PubMed ID: 8534541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.